1. Home
  2. Analysis
  3. Diprivan
  4. Anzemet

Diprivan and Anzemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprivan (propofol) and Anzemet (dolasetron mesylate). Common drug interactions include oedema peripheral among females.

The phase IV clinical study analyzes what interactions people have when they take Diprivan and Anzemet. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

On Jul, 12, 2026

18 people who take Diprivan and Anzemet together, and have interactions are studied.

Diprivan and Anzemet drug interactions.

What are the common drug interactions of Diprivan and Anzemet, by gender? *:

female:

  1. Oedema peripheral (superficial swelling)
  2. Osteopenia (a condition where bone mineral density is lower than normal)
  3. Bone disorder
  4. Bone erosion
  5. Bone fragmentation
  6. Bone pain
  7. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  8. Cellulitis (infection under the skin)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colitis ulcerative (inflammation of colon with ulcer)

male:

n/a

What are the common drug interactions of Diprivan and Anzemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Neuromuscular block prolonged
  2. Pulmonary oedema (fluid accumulation in the lungs)

40-49:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Drug ineffective

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Asthma
  3. Bone disorder
  4. Bone erosion
  5. Bone fragmentation
  6. Bone pain
  7. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  8. Cellulitis (infection under the skin)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colitis ulcerative (inflammation of colon with ulcer)

60+:

  1. Neuromuscular block prolonged

What are the existing conditions these people have? *

  1. Thrombocytopenia (decrease of platelets in blood): 8 people, 44.44%
  2. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 8 people, 44.44%
  3. Osteoporosis (bones weak and more likely to break): 8 people, 44.44%
  4. Depression: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and Anzemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diprivan and Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anzemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on propofol and dolasetron mesylate (the active ingredients of Diprivan and Anzemet, respectively), and Diprivan and Anzemet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.